In recent years, as many of the diseases for which allogeneic HPC transplantation is indicated are associated with advancing age; this therapy has been increasingly offered to patients in their sixth ...
Terumo Blood and Cell Technologies presents data on collection efficiency process with Spectra Optia(R) Apheresis System at major conferences Lakewood, Colorado, US, May 25, 2023 – Terumo Blood and ...
Autologous peripheral SCT has largely replaced BMT for the treatment of cancer in both adults and children. Cells are collected by apheresis. The technique has been widely used in France since its ...
The company also welcomes new board member and industry expert Cyrus K. Mirsaidi in furthering Sanguine's mission to integrate patients into the therapeutic research and development process. WALTHAM, ...
LAKEWOOD, Colo.--(BUSINESS WIRE)--Terumo BCT announced today that the Spectra Optia system mononuclear cell (MNC) collection protocol is now cleared by the U.S. Food and Drug Administration (FDA) and ...
Apheresis refers to a procedure where blood from a person (patient or donor) is passed through a medical device in order to extract the required components, such as red blood cells, platelets, plasma ...
MarketsandMarkets recently conducted a study on the "Apheresis Market - Applications (Plasmapheresis, Plateletpheresis, RBC/Erythrocytapheresis, Leukapheresis, Photopheresis), Procedures (Therapeutic ...
The global Apheresis Equipment Market is valued at $2.01 million in 2023 and is projected to reach a value of $2.20 million by 2032, growing at a Compound Annual Growth Rate (CAGR) of 3.7% from 2024 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback